RecruitingNCT05213598
Fontan Associated Liver Disease and the Evaluation of Biomarkers for Disease Severity Assessment
Studying Fontan-associated liver disease
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Principal Investigator
- Theo Heller, M.D.National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
- Enrollment
- 100 target
- Eligibility
- 18-100 years · All sexes
- Timeline
- 2022 – 2051
Study locations (1)
- National Institutes of Health Clinical Center, Bethesda, Maryland, United States
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT05213598 on ClinicalTrials.govOther trials for Fontan-associated liver disease
Additional recruiting or active studies for the same condition.
- RECRUITINGNCT07009132Cholate Clearance in Fontan and Heart FailureHepQuant, LLC
- RECRUITINGPHASE1NCT06324396IMProving DRug Dosing and Outcomes for Single VEntricle Patients With Fontan Associated Liver DiseaseChildren's Mercy Hospital Kansas City
- ACTIVE NOT RECRUITINGNCT03914196Fontan Associated Liver DiseaseChildren's Hospital Medical Center, Cincinnati